Results 151 to 160 of about 40,271 (232)

QSAR-Guided Virtual Screening and Molecular Dynamics Reveal Olaparib as a Repurposing Lead Against α-Synuclein Aggregation. [PDF]

Int J Mol Sci
Abdelsayed M, Boulaamane Y.
europepmc   +1 more source

Symptomatic hyperprolactinemia mimicking pituitary pathology in a child with Landau-Kleffner syndrome, autism spectrum disorder, and intellectual disability: a case report. [PDF]

J Med Case Rep
Shah SJ, Goradia V, Dattani AV, Palkamsetti S, Ravi U, Srivastava A.   +5 more
europepmc   +1 more source

Advancing Personalized Medicine in Psychiatry: A Descriptive Pilot Study Integrating Pharmacogenetics and Pharmacokinetics in Long-Acting Antipsychotic Treatment. [PDF]

Pharmaceutics
Gil-Rodriguez A, Recarey-Rama S, Vidal-Millares M, Toja-Camba FJ, Tajes M, Prado-Robles V, Durán-Maseda MJ, García MP, Rodríguez-Viyuela A, Sánchez-Fariña P, Abeledo-Lameiro MJ, Páramo M, Facal F, Arrojo Romero M, Diaz Pereira A, Mondelo-García C, Fernández-Ferreiro A, Carracedo A, Maroñas O.   +18 more
europepmc   +1 more source

A retrospective and in silico study on the augmentation of risperidone in the treatment of adolescent treatment-resistant depression: efficacy evaluation, adverse reaction analysis, and molecular mechanistic insights. [PDF]

Front Chem
Shen X, Yan Z.
europepmc   +1 more source

Integrative Multiomics Analysis Identifies DKK3 as a Germline Susceptibility-Related Regulator of Risperidone Response and Metabolic Risk in Schizophrenia. [PDF]

Hum Mutat
Zhang X, Li J, Sun Y, Hei G, Song X.
europepmc   +1 more source